[Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation].

[Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation].
Cancer Radiother. 2015 Oct 14;
Authors: Bibault JE, Oudoux A, Durand-Labrunie J, Mirabel X, Lartigau É, Kolesnikov-Gauthier H
Abstract
Stereotactic body radiation therapy is the standard treatment for inoperable patients with early-stage lung cancer. Local control rates range from 80 to 90 % 2 years after treatment. The role of positron emission tomography in patient selection is well known, but its use for target definition or therapeutic response evaluation is less clear. We reviewed the literature in order to assess the current state of knowledge in this area.
PMID: 26476702 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - October 14, 2015 Category: Cancer & Oncology Authors: Bibault JE, Oudoux A, Durand-Labrunie J, Mirabel X, Lartigau É, Kolesnikov-Gauthier H Tags: Cancer Radiother Source Type: research